The FDA has approved Ampio Pharmaceuticals' (AMPE) request to start treating 15 patients as part...

|About: Ampio Pharmaceuticals, Inc. (AMPE)|By:, SA News Editor

The FDA has approved Ampio Pharmaceuticals' (AMPE) request to start treating 15 patients as part of a two-stage trial of the company's Ampion anti-inflammatory treatment for osteoarthritis of the knee. The first phase of the study will involve 320 adults. Osteoarthritis (OA) is the most common form of arthritis, affecting 27M people in the U.S. (PR)